´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10
±³À°ÀÏÀÚ : 2023-05-10
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º, ±×·£µåº¼·ë(5F)
±³À°ÁÖÁ¦ : IASS 2023 (Çмú´ëȸ)
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ
´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674
À̸ÞÀÏ : IASS2022@humming.co.kr
±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í ÇǺΰú Àü¹®ÀÇ : 5¸¸¿ø·¹Áö´øÆ®, ¿¬±¸¿ø : 2¸¸¿øºñȸ¿ø : 50¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:20~09:40 What¡¯s new in itch mechanism and therapeutic approaches for atopic dermatitis? Jiehyun Jeon(Korea Univ.)
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:40~10:00 Characteristics for pediatric atopic dermatitis : What¡¯s the different adult atopic dermatitis? Sang Eun Lee(Yonsei Univ.)
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:00~10:20 Understanding of skin microbiome in atopic dermatitis for advance atopic dermatitis treatment Jihyun Lee(Catholic Univ.)
Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:20~10:30 Q&A ( )
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:30~11:10 Introduction of the concept of minimal disease activity Mark Kirchhof(Ottawa Univ.)
Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:10~11:20 Q&A ( )
ÈÞ½Ä 05¿ù 10ÀÏ 11:20~11:35 Coffee Break ( )
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:35~12:15 Can treatment impact the natural course of atopic dermatitis and comorbidity? Eric simpson(Oregon Health and Science Univ.)
Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:15~12:25 Q&A ( )
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:25~12:45 Prominent role of type 2 inflammation in skin diseases: beyond atopic dermatitis (Jiyoung Ahn)
Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:45~12:55 Q&A ( )
½Ä»ç 05¿ù 10ÀÏ 12:55~13:20 Lunch ( )
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 13:20~14:00 Current learning on the applications of atopic dermatitis therapy in real-world practice Stephan Weidinger(Christian-Albrechts Univ.)
Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:00~14:10 Q&A ( )
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:10~14:50 How does baricitinib real-world evidence compare to randomized controlled trials? Andreas Wollenberg(Ludwig-Maximilian Univ.)
Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:50~15:00 Q&A ( )
ÈÞ½Ä 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:00~15:15 Coffee Break ( )
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:15~15:55 Long-term perspectives in atopic dermatitis Chih-Ho Hong(British Columbia Univ.)
Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:55~16:05 Q&A ( )
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:05~16:25 Treat-to-target in atopic dermatitis : an important strategy for successful treatment Chan Ho Na(Chosun Univ.)
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:25~16:45 Optimal use of JAK inhibitors for atopic dermatitis based on real-world experiences Min Kyung Shin(Kyung Hee Univ.)
±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:45~17:05 Update on the treatment of pediatric atopic dermatitis Jung-Im Na(Seoul National Univ.)
Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 17:05~17:15 Q&A ( )